Can smartphone apps and continuous glucose monitors help tame type 2 diabetes?

NCT ID NCT07642830

ENROLLING_BY_INVITATION Disease control Sponsor: Chang Gung Memorial Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether using a continuous glucose monitor (CGM) along with a mobile app can help people with type 2 diabetes control their blood sugar better than standard care. Sixty adults will be randomly assigned to either the digital tool group or usual care, and their HbA1c and time in range will be measured after 12 weeks. The goal is to see if these technologies improve glucose management and patient satisfaction.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Continuous Glucose Monitor (CGM) device and mobile app
What this could lead to: If successful, this could show that digital tools help people with type 2 diabetes better manage their blood sugar levels.
What could go wrong: This is a small, early-stage study with only 60 participants, so results may not apply to everyone. It is observational, so it cannot prove cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 2

Contacts and locations

Locations

Chang Gung Memorial Hospital

Taoyuan, Taiwan, 333, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.